No association of CpG island methylator phenotype and colorectal cancer survival: population-based study

被引：0
作者：
Min Jia
Lina Jansen
Viola Walter
Katrin Tagscherer
Wilfried Roth
Esther Herpel
Matthias Kloor
Hendrik Bläker
Jenny Chang-Claude
Hermann Brenner
Michael Hoffmeister
机构：
[1] German Cancer Research Center (DKFZ),Division of Clinical Epidemiology and Aging Research
[2] Institute of Pathology,Department of Applied Tumor Biology
[3] Heidelberg University Hospital,Division of Cancer Epidemiology
[4] Institute of Pathology,Division of Preventive Oncology
[5] University Medical Center Mainz,undefined
[6] NCT Tissue Bank,undefined
[7] National Center for Tumor Diseases (NCT),undefined
[8] Institute of Pathology,undefined
[9] Heidelberg University Hospital,undefined
[10] Institute of Pathology,undefined
[11] Charité University Medicine,undefined
[12] German Cancer Research Center (DKFZ),undefined
[13] German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT),undefined
[14] German Cancer Consortium (DKTK),undefined
[15] German Cancer Research Center (DKFZ),undefined
来源：
British Journal of Cancer | 2016年 / 115卷
关键词：
molecular pathological epidemiology; DNA methylation; malignant; subtype; prognosis; colorectal cancer; CRC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1359 / 1366
页数：7
相关论文
共 50 条
  • [41] Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)
    Chang, Shih-Ching
    Li, Anna Fen-Yau
    Lin, Pei-Ching
    Lin, Chun-Chi
    Lin, Hung-Hsin
    Huang, Shen-Chieh
    Lin, Chien-Hsing
    Liang, Wen-Yi
    Chen, Wei-Shone
    Jiang, Jeng-Kai
    Lin, Jen-Kou
    Yang, Shung-Haur
    Lan, Yuan-Tzu
    CANCERS, 2020, 12 (11) : 1 - 16
  • [42] One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study
    Van Guelpen, Bethany
    Dahlin, Anna M.
    Hultdin, Johan
    Eklof, Vincy
    Johansson, Ingegerd
    Henriksson, Maria L.
    Cullman, Inger
    Hallmans, Goran
    Palmqvist, Richard
    CANCER CAUSES & CONTROL, 2010, 21 (04) : 557 - 566
  • [43] The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
    Cohen, Stacey A.
    Yu, Ming
    Baker, Kelsey
    Redman, Mary
    Wu, Chen
    Heinzerling, Tai J.
    Wirtz, Ralph M.
    Charalambous, Elpida
    Pentheroudakis, George
    Kotoula, Vassiliki
    Kalogeras, Konstantine T.
    Fountzilas, George
    Grady, William M.
    CLINICAL EPIGENETICS, 2017, 9
  • [44] CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer
    Shiovitz, Stacey
    Bertagnolli, Monica M.
    Renfro, Lindsay A.
    Nam, Eunmi
    Foster, Nathan R.
    Dzieciatkowski, Slavomir
    Luo, Yanxin
    Lao, Victoria Valinluck
    Monnat, Raymond J., Jr.
    Emond, Mary J.
    Maizels, Nancy
    Niedzwiecki, Donna
    Goldberg, Richard M.
    Saltz, Leonard B.
    Venook, Alan
    Warren, Robert S.
    Grady, William M.
    GASTROENTEROLOGY, 2014, 147 (03) : 637 - 645
  • [45] The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status
    Dahlin, Anna M.
    Palmqvist, Richard
    Henriksson, Maria L.
    Jacobsson, Maria
    Eklof, Vincy
    Rutegard, Jorgen
    Oberg, Ake
    Van Guelpen, Bethany R.
    CLINICAL CANCER RESEARCH, 2010, 16 (06) : 1845 - 1855
  • [46] The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
    Stacey A. Cohen
    Ming Yu
    Kelsey Baker
    Mary Redman
    Chen Wu
    Tai J. Heinzerling
    Ralph M. Wirtz
    Elpida Charalambous
    George Pentheroudakis
    Vassiliki Kotoula
    Konstantine T. Kalogeras
    George Fountzilas
    William M. Grady
    Clinical Epigenetics, 2017, 9
  • [47] Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer
    Ichimura, Norihisa
    Shinjo, Keiko
    An, Byonggu
    Shimizu, Yasuhiro
    Yamao, Kenji
    Ohka, Fumiharu
    Katsushima, Keisuke
    Hatanaka, Akira
    Tojo, Masayuki
    Yamamoto, Eiichiro
    Suzuki, Hiromu
    Ueda, Minoru
    Kondo, Yutaka
    CANCER PREVENTION RESEARCH, 2015, 8 (08) : 702 - 711
  • [48] Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis
    Juo, Y. Y.
    Johnston, F. M.
    Zhang, D. Y.
    Juo, H. H.
    Wang, H.
    Pappou, E. P.
    Yu, T.
    Easwaran, H.
    Baylin, S.
    van Engeland, M.
    Ahuja, N.
    ANNALS OF ONCOLOGY, 2014, 25 (12) : 2314 - 2327
  • [49] The CpG island methylator phenotype in breast cancer is associated with the lobular subtype
    Roessler, Jessica
    Ammerpohl, Ole
    Gutwein, Jana
    Steinemann, Doris
    Schlegelberger, Brigitte
    Weyer, Veronika
    Sariyar, Murat
    Geffers, Robert
    Arnold, Norbert
    Schmutzler, Rita
    Bartram, Claus R.
    Heinrich, Tilman
    Abbas, Mahmoud
    Antonopoulos, Wiebke
    Schipper, Elisa
    Hasemeier, Britta
    Kreipe, Hans
    Lehmann, Ulrich
    EPIGENOMICS, 2015, 7 (02) : 187 - 199
  • [50] DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer
    Nosho, Katsuhiko
    Shima, Kaori
    Irahara, Natsumi
    Kure, Shoko
    Baba, Yoshifumi
    Kirkner, Gregory J.
    Chen, Li
    Gokhale, Sumita
    Hazra, Aditi
    Spiegelman, Donna
    Giovannucci, Edward L.
    Jaenisch, Rudolf
    Fuchs, Charles S.
    Ogino, Shuji
    CLINICAL CANCER RESEARCH, 2009, 15 (11) : 3663 - 3671
12345